IPG1094 Phase I Study for China Healthy Participants
NCT07679113
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
IPG1094 Tablets
Sponsor
Nanjing Immunophage Biotech Co., Ltd
Collaborators
[object Object]